WeVote
Log In

Bill

Bill

HF 1093

Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and recommendations required.

2025-2026 Regular Session Introduced by Robert Bierman and 9 co-sponsors

Minnesota bill directs state health agency to create prescription drug bulk-purchasing program to negotiate lower medication prices for eligible residents and reduce costs.

Authors added Hemmingsen-Jaeger and Hollins
#drugsandmedicine #humanservicesandhumanservicesdepartment
0
WeVote Research Nonpartisan
Bill Summary · HF 1093

Legislative bill overview

HF 1093 directs Minnesota's Commissioner of Human Services to establish a prescription drug purchasing program that would allow the state to negotiate and bulk-purchase medications on behalf of eligible residents. The bill specifies program authority, defines eligibility requirements, and requires the commissioner to make recommendations about implementation and potential savings.

Why is this important

Prescription drug costs are a major healthcare expense for individuals and states. A state-level purchasing program could leverage Minnesota's population size to negotiate lower drug prices, potentially reducing out-of-pocket costs for participants and state Medicaid spending. This represents one approach states are exploring as federal drug price negotiations expand under recent legislation.

Potential points of contention

  • Pharmaceutical industry opposition: Drug manufacturers may argue the program undercuts innovation incentives and profitability, potentially reducing research investment in new treatments
  • Program cost and feasibility: Establishing infrastructure for bulk purchasing, negotiation, and distribution carries upfront costs; unclear whether savings would offset administrative expenses
  • Eligibility scope: Definition of "eligible residents" will determine program reach—broader eligibility increases costs but narrower eligibility limits impact for those most burdened by drug costs
  • Federal coordination: Potential overlap or conflict with federal Medicare drug price negotiation provisions and existing state Medicaid programs requires careful policy coordination

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.